Impact of time to relapse (TTR) and metastasectomy (MTS) on survival in leiomyosarcoma (LMS): A CanSaRCC study.
Abdulazeez Salawu(Princess Margaret Cancer Centre), Abha A. Gupta(Roche (Switzerland)), Geoffrey Alan Watson(Mount Sinai Hospital), Carolyn Nessim(University of Ottawa), Caroline L. Holloway, Albiruni Ryan Abdul Razak(Roche (Switzerland)), Erica C. Koch Hein(University Health Network), Hagit Peretz Soroka(University Health Network), Brookelyn Biffart(University of British Columbia)
Cited by 1
Related Papers
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
|Annals of Surgical Oncology|2021|251
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma
|Journal of Clinical Oncology|2016|165
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
|Clinical Cancer Research|2019|116
Ewing‐like sarcoma: An emerging family of round cell sarcomas
|Journal of Cellular Physiology|2018|81
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
|European Journal of Cancer|2019|81